Grove J - Search Results

1

Cerebrospinal fluid GABA and homocarnosine concentrations in patients with Friedreich's ataxia, Parkinson's disease, and Huntington's chorea.

Bonnet AM, Tell G, Schechter PJ, Grove J, Saint-Hilaire MH, De Smet Y, Agid Y. Bonnet AM, et al. Among authors: grove j. Mov Disord. 1987;2(2):117-23. doi: 10.1002/mds.870020206. Mov Disord. 1987. PMID: 2973560

2

Cerebrospinal fluid GABA as an index of brain GABA activity.

Grove J, Palfreyman MG, Schechter PJ. Grove J, et al. Clin Neuropharmacol. 1983;6(3):223-9. doi: 10.1097/00002826-198309000-00004. Clin Neuropharmacol. 1983. PMID: 6313185 No abstract available.

3

Artifactual increases in the concentration of free GABA in samples of human cerebrospinal fluid are due to degradation of homocarnosine.

Grove J, Schechter PJ, Tell G, Rumbach L, Marescaux C, Warter JM, Koch-Weser J. Grove J, et al. J Neurochem. 1982 Oct;39(4):1061-5. doi: 10.1111/j.1471-4159.1982.tb11497.x. J Neurochem. 1982. PMID: 7119781

4

Concentration gradients of free and total gamma-aminobutyric acid and homocarnosine in human CSF: comparison of suboccipital and lumbar sampling.

Grove J, Schechter PJ, Hanke NF, de Smet Y, Agid Y, Tell G, Koch-Weser J. Grove J, et al. J Neurochem. 1982 Dec;39(6):1618-22. doi: 10.1111/j.1471-4159.1982.tb07995.x. J Neurochem. 1982. PMID: 7142991

5

Increased gamma-aminobutyric acid (GABA), homocarnosine and beta-alanine in cerebrospinal fluid of patients treated with gamma-vinyl GABA (4-amino-hex-5-enoic acid).

Grove J, Schechter PJ, Tell G, Koch-Weser J, Sjoerdsma A, Warter JM, Marescaux C, Rumbach L. Grove J, et al. Life Sci. 1981 May 21;28(21):2431-9. doi: 10.1016/0024-3205(81)90511-7. Life Sci. 1981. PMID: 6789022 No abstract available.

6

Biochemical and clinical effects of gamma-vinyl GABA in patients with epilepsy.

Schechter PJ, Hanke NF, Grove J, Huebert N, Sjoerdsma A. Schechter PJ, et al. Among authors: grove j. Neurology. 1984 Feb;34(2):182-6. doi: 10.1212/wnl.34.2.182. Neurology. 1984. PMID: 6538006 Clinical Trial.

7

Increased CSF gamma-aminobutyric acid after treatment with gamma-vinyl GABA.

Grove J, Tell G, Schechter PJ, Koch-Weser J, Warter JM, Marescaux C, Rumbach L. Grove J, et al. Lancet. 1980 Sep 20;2(8195 pt 1):647. doi: 10.1016/s0140-6736(80)90318-9. Lancet. 1980. PMID: 6107437 No abstract available.

8

Attempts to correlate alterations in brain GABA metabolism by GABA-T inhibitors with their anticonvulsant effects.

Schechter PJ, Tranier Y, Grove J. Schechter PJ, et al. Among authors: grove j. Adv Exp Med Biol. 1979;123:43-57. doi: 10.1007/978-1-4899-5199-1_3. Adv Exp Med Biol. 1979. PMID: 517278 No abstract available.

9

Effect of n-dipropylacetate on amino acid concentrations in mouse brain: correlations with anti-convulsant activity.

Schechter PJ, Tranier Y, Grove J. Schechter PJ, et al. Among authors: grove j. J Neurochem. 1978 Nov;31(5):1325-7. doi: 10.1111/j.1471-4159.1978.tb06258.x. J Neurochem. 1978. PMID: 359762 No abstract available.

10

Gabuculine and isogabaculine: in vivo biochemistry and pharmacology in mice.

Schechter PJ, Tranier Y, Grove J. Schechter PJ, et al. Among authors: grove j. Life Sci. 1979 Mar 26;24(13):1173-82. doi: 10.1016/0024-3205(79)90054-7. Life Sci. 1979. PMID: 449617 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

774 results

Search Page

Filters